glp-1 shortage As Drug Ends, Why Will Patients Pay More? How Markets Solved the GLP-1

Clinical Application Guidance: Therapeutic selection should be individualized based on patient-specific factors, such as cardiovascular status, renal function, administration route preferences, and tolerability, with ongoing attention to emerging evidence to refine treatment strategies

Zheng, Zhikai, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, and Junjie Gao

Diabetes Ther 16 , 813849 (2025)

doi: 10.2337/dc18-0680

Gastric electrical stimulation for medically refractory gastroparesis

Challenges include gastrointestinal side effects, nutritional deficiencies due to calorie reduction, muscle and bone loss, low long-term adherence with subsequent weight regain, and high costs, resulting in low cost-effectiveness